Blueberry extract attenuates DSS-induced inflammatory bowel disease in mice through inhibiting ER stress-mediated colonic apoptosis in mice

Jun Wang,Xin-Yu Wang,Zhong-Yu Yuan,Xiao-Han Wang,Yu-Ying Guan,Ji-Xiao Zhu,Wei-Feng Huang,Qing Liu,Guang-Hui Xu,Litao Yi
DOI: https://doi.org/10.1039/d4fo00194j
IF: 6.3173
2024-08-24
Food & Function
Abstract:Inflammatory bowel disease (IBD) is a chronic, debilitating condition with limited therapeutic options. Dietary components like blueberry have emerged as potential modulators of inflammation and tissue repair in gastrointestinal diseases. This study investigated endoplasmic reticulum (ER) stress-apoptosis mediated protective effects of blueberry in ameliorating dextran sulfate sodium (DSS)-induced IBD. Firstly, a total of 86 anthocyanin compounds were identified in blueberry extract by LC-MS spectroscopy including 35 cyanidin, 9 delphinidin, 14 malvidin, 10 peonidin, and 9 petunidin. Then, the animals study showed that blueberry supplementation notably ameliorated DSS-induced IBD symptoms, evident from improved histopathological scores and reduced disease activity index (DAI) score. In addition, blueberry attenuated ER stress by inhibiting the colonic PERK/eIF2α/ATF4/CHOP signaling pathway. Furthermore, blueberry inhibited the expression of the pro-apoptotic protein, caspase-3, as well as decreased the colonic apoptosis by Tunnel assay, but not affect the expression of anti-apoptotic proteins bcl-2 and bcl-xl. Lastly, blueberry enhanced intestinal barrier by upregulating ZO-1, Claudin-1, Occludin, and E-cadherin. In conclusion, blueberry demonstrates therapeutic potential against DSS-induced IBD-like symptoms in mice, possibly by regulating ER stress-mediated apoptosis pathways. These findings suggest that blueberry might be an effective dietary intervention for IBD management.
biochemistry & molecular biology,food science & technology
What problem does this paper attempt to address?